We are live on ! Find out more
MRCM

M&R Capital Management Portfolio holdings

AUM $454M
1-Year Est. Return 40.11%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$364M
AUM Growth
+$9.44M
Cap. Flow
-$14M
Cap. Flow %
-3.86%
Top 10 Hldgs %
42.64%
Holding
624
New
166
Increased
90
Reduced
129
Closed
20

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$325K
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$158K
3
QQQ icon
Invesco QQQ Trust
QQQ
+$151K
4
LLY icon
Eli Lilly
LLY
+$144K
5
CVX icon
Chevron
CVX
+$118K

Top Sells

Rank Stock Value
1
WOOF icon
Petco
WOOF
+$1.83M
2
FDX icon
FedEx
FDX
+$1.64M
3
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$1.51M
4
DIS icon
Walt Disney
DIS
+$1.17M
5
WBD icon
Warner Bros
WBD
+$1.08M

Sector Composition

Rank Sector Weight
1 Financials 20.47%
2 Technology 19.27%
3 Healthcare 15.16%
4 Communication Services 10.94%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAI
176
Western Asset Investment Grade Income Fund
PAI
$114M
$117K 0.03%
10,100
– –
ESBA icon
177
Empire State Realty Series ES
ESBA
$1.3B
$116K 0.03%
17,692
– –
MO icon
178
Altria Group
MO
$115B
$114K 0.03%
2,486
-1,417
-36% -$64.2K
IYH icon
179
iShares US Healthcare ETF
IYH
$3.74B
$113K 0.03%
2,000
– –
AVY icon
180
Avery Dennison
AVY
$13.5B
$113K 0.03%
625
– –
IEFA icon
181
iShares Core MSCI EAFE ETF
IEFA
$195B
$112K 0.03%
1,815
– –
REGN icon
182
Regeneron Pharmaceuticals
REGN
$81.8B
$108K 0.03%
150
-90
-38% -$66.4K
VWO icon
183
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$106K 0.03%
2,717
-950
-26% -$36.2K
PCH
184
DELISTED
PotlatchDeltic
PCH
$106K 0.03%
2,400
– –
XRAY icon
185
Dentsply Sirona
XRAY
$2.22B
$105K 0.03%
3,302
-599
-15% -$18.1K
CSSE
186
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$103K 0.03%
20,160
– –
IWM icon
187
iShares Russell 2000 ETF
IWM
$80.8B
$100K 0.03%
+574
New +$102K
XBI icon
188
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$99.6K 0.03%
1,200
– –
VIG icon
189
Vanguard Dividend Appreciation ETF
VIG
$113B
$96.9K 0.03%
638
-78
-11% -$11.6K
CWB icon
190
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.59B
$96.5K 0.03%
1,500
– –
SO icon
191
Southern Company
SO
$102B
$96.4K 0.03%
1,350
– –
ZBH icon
192
Zimmer Biomet
ZBH
$19.2B
$95.2K 0.03%
747
– –
IJH icon
193
iShares Core S&P Mid-Cap ETF
IJH
$124B
$90.7K 0.03%
1,875
– –
BNS icon
194
Scotiabank
BNS
$113B
$90.1K 0.02%
1,840
– –
YUMC icon
195
Yum China
YUMC
$15.3B
$88K 0.02%
1,610
– –
SHEL icon
196
Shell
SHEL
$250B
$84.5K 0.02%
1,484
-249
-14% -$13.7K
VONE icon
197
Vanguard Russell 1000 ETF
VONE
$8.64B
$83.6K 0.02%
480
– –
VOE icon
198
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.3B
$83.2K 0.02%
615
– –
TSLA icon
199
Tesla
TSLA
$1.38T
$83.1K 0.02%
675
– –
RSP icon
200
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$83.1K 0.02%
+588
New +$82.2K
6 7
8
9 10

Similar funds

EDRIA
Edmonds Duncan Registered Investment Advisors Lawrence, Kansas $457M AUM 23% 1-Year Est. Return
SFP
Sweet Financial Partners Fairmont, Minnesota $462M AUM 26.73% 1-Year Est. Return
AC
Albar Capital London, United Kingdom $445M AUM 55.79% 1-Year Est. Return
NIC
Northwest Investment Counselors Lake Oswego, Oregon $442M AUM 29.9% 1-Year Est. Return
WCA
Waypoint Capital Advisors Minneapolis, Minnesota $470M AUM 32.8% 1-Year Est. Return
KC
Kingfisher Capital Charlotte, North Carolina $437M AUM 41.72% 1-Year Est. Return
SIGI
Susquehanna International Group (Ireland) Dublin, Ireland $472M AUM 25.62% 1-Year Est. Return
FPFS
First Personal Financial Services Charlotte, North Carolina $473M AUM 28.33% 1-Year Est. Return

M&R Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, M&R Capital Management held 624 positions worth $364M, up 2.7% from $354M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

M&R Capital Management withdrew a net $14M in Q4 2022, closing 20 positions and reducing 129 holdings. Its most notable exit was iShares Core S&P Total US Stock Market ETF, an estimated $160K position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

Against the trend, M&R Capital Management opened a new position in Invesco QQQ Trust worth $145K.

  • M&R Capital Management's largest Q4 2022 buy was Invesco QQQ Trust: 545 shares worth $145K.
  • M&R Capital Management added most to Bristol-Myers Squibb in Q4 2022, an estimated $325K increase.
  • M&R Capital Management's biggest Q4 2022 reduction was Petco, cutting an estimated $1.83M.
  • M&R Capital Management fully exited iShares Core S&P Total US Stock Market ETF in Q4 2022, selling an estimated $160K.
  • M&R Capital Management's ten largest holdings make up 43% of its $364M portfolio in Q4 2022.
  • M&R Capital Management opened 166 new positions and closed 20 in Q4 2022.
  • M&R Capital Management's portfolio value rose 2.7% quarter-over-quarter to $364M.

Based on M&R Capital Management's 13F filing for Q4 2022, filed 11 Jan 2023.